Characteristic Evaluation of Gel Formulation Containing Niosomes of Melatonin or Its Derivative and Mucoadhesive Properties Using ATR-FTIR Spectroscopy.
ATR-FTIR spectroscopy
gel base effect
melatonin niosome gel
mucosa
Journal
Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357
Informations de publication
Date de publication:
02 Apr 2021
02 Apr 2021
Historique:
received:
09
03
2021
revised:
27
03
2021
accepted:
29
03
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
Chitosan or polyvinyl pyrrolidone (PVP) were used in combination with hydroxypropyl methylcellulose (HPMC) and poloxamer 407 (P407) as gelling agents for oral drug delivery. The performance interaction with mucin of chitosan-composed gel (F1) and PVP-composed gel (F2) was compared using attenuated total reflectance-Fourier-transform infrared (ATR-FTIR) spectroscopy at controlled temperatures of 25 and 37 °C for 1 and 5 min. F1 containing niosome-entrapped melatonin or its derivatives was investigated for mucoadhesive interaction on mucosa by ATR-FTIR spectroscopy under the same conditions. The results showed that F1-treated mucin gave a significantly lower amide I/amide II ratio than untreated mucin and F2-treated mucin did within 1 min, suggesting improved rapid affinity between mucin and chitosan. The spectra of mucosa treated with F1 incorporating niosomes of melatonin or its derivatives showed peak shifts at C=O (amide I), N-H (amide II), and carbohydrate regions and an associated decrease in the amide I/amide II ratio and increase in the carbohydrate/amide II ratio. These results indicated electrostatic interaction and hydrogen bonding between chitosan and mucin on the mucosa. In conclusion, the molecular interaction between gels and mucin/mucosa detected at amide I and amide II of proteins and the carbohydrate region could lead to an improved mucoadhesive property of the gel on the mucosa.
Identifiants
pubmed: 33918458
pii: polym13071142
doi: 10.3390/polym13071142
pmc: PMC8038236
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Biomacromolecules. 2003 Sep-Oct;4(5):1184-90
pubmed: 12959582
Rocz Akad Med Bialymst. 2005;50:334-8
pubmed: 16358996
Pharm Res. 2012 Aug;29(8):2329-40
pubmed: 22565639
Pharmaceutics. 2017 Nov 20;9(4):
pubmed: 29156634
Biochim Biophys Acta. 2015 Apr;1848(4):1032-40
pubmed: 25602914
Carbohydr Polym. 2017 Feb 10;157:361-370
pubmed: 27987939
Colloids Surf B Biointerfaces. 2015 Jan 1;125:291-9
pubmed: 25524220
AAPS PharmSciTech. 2011 Jun;12(2):683-92
pubmed: 21594728
Eur J Clin Pharmacol. 2015 Aug;71(8):901-9
pubmed: 26008214
J Biol Chem. 1999 Nov 5;274(45):31751-4
pubmed: 10542193
Biochim Biophys Acta. 2006 Jul;1758(7):858-67
pubmed: 16566893
J Pharm Sci. 1997 Oct;86(10):1115-9
pubmed: 9344167
J Pharm Pharmacol. 2001 Dec;53(12):1589-99
pubmed: 11804389
Sci Rep. 2017 Apr 20;7:46405
pubmed: 28425498
Carbohydr Polym. 2016 Nov 20;153:176-186
pubmed: 27561485
J Control Release. 2014 Jul 10;185:22-36
pubmed: 24747765
J Colloid Interface Sci. 2012 Jun 15;376(1):289-95
pubmed: 22469069
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):843-53
pubmed: 23851076
Drug Res (Stuttg). 2016 Apr;66(4):169-73
pubmed: 26514093
J Pharm Sci. 2005 Dec;94(12):2777-88
pubmed: 16258996
Macromol Biosci. 2017 Aug;17(8):
pubmed: 28378910
Cancer Detect Prev. 2007;31(3):244-53
pubmed: 17646059
Ther Deliv. 2018 May;9(5):343-357
pubmed: 29681235
Colloids Surf B Biointerfaces. 2015 Dec 1;136:799-808
pubmed: 26529388
Pharm Res. 2006 Dec;23(12):2709-28
pubmed: 17096184
Clin Pharmacokinet. 2001;40(2):77-84
pubmed: 11286325
Colloids Surf B Biointerfaces. 2012 Apr 1;92:353-9
pubmed: 22209653